These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 199544)

  • 21. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis].
    Urazova LN; Podoplekin VD; Odintsova LN; Lepekhin AV
    Lab Delo; 1989; (5):73-4. PubMed ID: 2473271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides.
    Sculley DG; Sculley TB; Pope JH
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2253-8. PubMed ID: 3020161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Epstein-Barr virus and infectious mononucleosis.
    Royston I
    Lancet; 1973 Nov; 2(7838):1152. PubMed ID: 4128043
    [No Abstract]   [Full Text] [Related]  

  • 28. Colonies of EBNA-positive cells in soft agar from peripheral leukocytes of infectious mononucleosis patients.
    Hinuma Y; Katsuki T
    Int J Cancer; 1978 Apr; 21(4):426-31. PubMed ID: 78908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection].
    Konno M
    Hokkaido Igaku Zasshi; 1989 Mar; 64(2):125-38. PubMed ID: 2543617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
    Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
    BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Epstein-Barr virus antigens with enzyme-conjugated antibody.
    Granlund DJ; Andrese AP
    Int J Cancer; 1977 Oct; 20(4):495-9. PubMed ID: 72045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. IV. Development of T-cell memory in convalescent infectious mononucleosis patients.
    Rickinson AB; Moss DJ; Pope JH; Ahlberg N
    Int J Cancer; 1980 Jan; 25(1):59-65. PubMed ID: 6249763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants.
    Dohno S; Maeda A; Ishiura Y; Sato T; Fujieda M; Wakiguchi H
    Pediatr Int; 2010 Aug; 52(4):536-40. PubMed ID: 20113421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Epstein-Barr virus (EBV) in human pathology. II. Serologic profiles of EBV infections.
    Didier J; Dalens M; Chabanon G; Icart J; Enjalbert L
    Biomedicine; 1978; 28(1):54-62. PubMed ID: 208675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis.
    Smith RS; Rhodes G; Vaughan JH; Horwitz CA; Geltosky JE; Whalley AS
    J Infect Dis; 1986 Nov; 154(5):885-9. PubMed ID: 3021871
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro evaluation of cell-mediated immunity to Epstein-Barr herpesvirus by cell migration inhibition tests.
    Lai PK; Alpers MP; Mackay Scollay EM
    J Natl Cancer Inst; 1975 Dec; 55(6):1319-22. PubMed ID: 173867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
    J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation.
    Pope JH; Moss DJ
    IARC Sci Publ (1971); 1978; (24 Pt 2):617-22. PubMed ID: 221385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.